Company THERACLION N Euronext Paris
Equities
FR0010120402
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- EUR | - |
Business Summary
- sale of equipment (66.1%);
- sale of consumables (27.8%);
- provision of after-sales services (6.1%).
Export accounts for 96.6% of net sales.
Sales per Business
EUR in Million | 2023 | Weight | Delta |
---|---|---|---|
Equipment
65.9
%
| 1 | 65.9 % | - |
Consumables
27.7
%
| 1 | 27.7 % | - |
Services
6.4
%
| 0 | 6.4 % | - |
Sales per region
EUR in Million | 2023 | Weight | Delta |
---|---|---|---|
Germany, China, Hong Kong, Macao and United Kingdom
100.0
%
| 2 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Martin Deterre
CEO | Chief Executive Officer | - | 19-12-31 |
Laurence Géricot
DFI | Director of Finance/CFO | - | - |
Gaylord Tallec
COO | Chief Operating Officer | - | - |
Jeremie Anquez
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michel Nuta
CTO | Chief Tech/Sci/R&D Officer | - | 12-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ari Kellen
BRD | Director/Board Member | - | 19-02-12 |
Renaud Saleur
BRD | Director/Board Member | - | 18-01-31 |
Yann Duchesne
CHM | Chairman | 67 | 22-01-23 |
Samuel G. Levy
BRD | Director/Board Member | - | 16-05-11 |
Mehdi El Glaoui
BRD | Director/Board Member | - | 21-06-21 |
Shawn Langer
BRD | Director/Board Member | - | 19-02-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,263,960 | 31,520,939 ( 71.21 %) | 22,865 ( 0.0517 %) | 71.21 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+12.50% | 228B | |
+14.52% | 196B | |
+17.51% | 141B | |
+28.96% | 110B | |
+1.37% | 65.88B | |
+18.16% | 54.3B | |
+7.63% | 52.39B | |
+10.95% | 45.22B | |
+5.10% | 37.12B |
- Stock Market
- Equities
- ALTHE Stock
- Stock
- Company THERACLION N